Composition
- Active ingredients
- FOLLITROPIN ALFA/BETA 37.5 IU/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- FOLLITROPIN ALFA/BETA 150 IU/VIAL · InjectableBLA021765-003 · Discontinued
- FOLLITROPIN ALFA/BETA 37.5 IU/VIAL · InjectableThis page
- FOLLITROPIN ALFA/BETA 150 IU/VIAL · InjectableBLA020378-002 · Discontinued
- FOLLITROPIN ALFA/BETA 450 IU/VIAL · InjectableBLA020378-005 · Prescription
- FOLLITROPIN ALFA/BETA 37.5 IU/VIAL · InjectableBLA020378-003 · Discontinued
- FOLLITROPIN ALFA/BETA 75 IU/VIAL · InjectableBLA020378-001 · Discontinued
- FOLLITROPIN ALFA/BETA 1,050 IU/VIAL · InjectableBLA020378-004 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA021765.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Gonal-F
- Active substance
- follitropin alfa/beta
- Route
- Subcutaneous
- Dosage form
- Injectable
- Applicant
- Emd Serono
- Status
- Discontinued
- FDA approval
- 25 Mar 2004
- Application
- BLA021765-001